• PHYSICIANS
• GreenLight
• Reimbursement
• Training
• Clinical
• Calendar
• Contact Us

Return to GreenLight Laser Therapy

GreenLight HPS EA (Extended Applications) Fiber For the treatment of Bladder Tumors and Urethral Strictures

According to the American Cancer Society, in 2007 more than 67,000 new cases of urinary bladder cancer were diagnosed in the United States. ¹ Superficial bladder tumors, involving only the inner lining of the bladder, account for approximately 70 to 80% of all bladder tumors. ^{2, 3}

The new GreenLight HPS EA Fiber is designed to extend the proven GreenLight technology beyond the treatment of BPH to the treatment of Bladder Tumors and Urethral Strictures.

GreenLight HPS Advantages in the treatment of Bladder Tumors —

• Avascular Procedure — Virtually no bledding because of the high affinity of the GreenLight wavelength to oxyhemoglobin. ⁴
• Controlled Depth of Penetration — The 532 nm laser energy of GreenLight has an optical penetration depth of 0.8 mm. This minimal depth of penetration eliminates the deeper damage that sometimes leads to secondary hemorrhage. ⁴
• Avoiding the Obturator Reflex — GreenLight does not conduct electricity therefore eliminating the risk of stimulating the obturator nerve and creating a spasm of the patient's obturator muscle.
• Patient Comfort and Tolerance — The EA Fiber can be put through a 21 French scope which is smaller than the resectoscope used in traditional surgery.

For more information on GreenLight Laser Treatment for Superficial Bladder Tumors Paper, click here.

• GreenLight EA Fiber Press Release (pdf)

---

Reference & Partial Bibliography